- Smyth, E., Van Cutsem, E., Al-Batran, S., Muro, K., Ferrándiz, A., Lorenzen, S.,… Tabernero, J., Janjigian, Y. (2026). Analysis of 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) administration in MATTERHORN: A randomized, phase 3 study of durvalumab (D) plus FLOT in resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma. Journal of Clinical Oncology, 44(2_suppl), 343-343. https://doi.org/10.1200/JCO.2026.44.2_suppl.343 (Meeting abstract)
Analysis of 5-fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) administration in MATTERHORN: A randomized, phase 3 study of durvalumab (D) plus FLOT in resectable gastric/gastroesophageal junction (G/GEJ) adenocarcinoma
on 1 de juny de 2026
with No hi ha comentaris
Deixa un comentari